Skip to Main Content
HBS Home
  • About
  • Academic Programs
  • Alumni
  • Faculty & Research
  • Baker Library
  • Giving
  • Harvard Business Review
  • Initiatives
  • News
  • Recruit
  • Map / Directions
Faculty & Research
  • Faculty
  • Research
  • Featured Topics
  • Academic Units
  • …→
  • Harvard Business School→
  • Faculty & Research→
  • Research
    • Research
    • Publications
    • Global Research Centers
    • Case Development
    • Initiatives & Projects
    • Research Services
    • Seminars & Conferences
    →
  • Publications→

Publications

Publications

Filter Results: (1,329) Arrow Down
Filter Results: (1,329) Arrow Down Arrow Up

Show Results For

  • All HBS Web  (1,329)
    • People  (1)
    • News  (333)
    • Research  (819)
    • Events  (1)
    • Multimedia  (8)
  • Faculty Publications  (593)

Show Results For

  • All HBS Web  (1,329)
    • People  (1)
    • News  (333)
    • Research  (819)
    • Events  (1)
    • Multimedia  (8)
  • Faculty Publications  (593)
← Page 39 of 1,329 Results →
  • Career Coach

Kaitlin Hearn

Kaitlin grew up in Canada and studied engineering, but has spent the bulk of her career in finance and consulting in New York. As a serial career switcher herself, Kaitlin is well positioned to help you think through the merits and... View Details
  • Summer 2023
  • Article

Do Policies to Increase Access to Treatment for Opioid Use Disorder Work?

By: Eric Barrette, Leemore S. Dafny and Karen Shen
Even among commercially insured individuals, opioid use disorder is undertreated in the United States: nearly half receive no treatment within six months of a new diagnosis. Using a difference-in-differences specification exploiting the extension of insurance parity... View Details
Keywords: Opioid Treatment; Medication-assisted Treatment; Substance Use Disorder; Private Insurance; Insurance; Health Care and Treatment
Citation
Find at Harvard
Purchase
Related
Barrette, Eric, Leemore S. Dafny, and Karen Shen. "Do Policies to Increase Access to Treatment for Opioid Use Disorder Work?" American Journal of Health Economics 9, no. 3 (Summer 2023): 297–330.
  • September 2022
  • Article

Giving a Buck or Making a Buck? Donations by Pharmaceutical Manufacturers to Independent Patient Assistance Charities

By: Leemore Dafny, Christopher Ody and Teresa Rokos
The federal Anti-Kickback Statute prohibits biopharmaceutical manufacturers from directly covering Medicare enrollees’ out-of-pocket spending for the drugs they manufacture, but manufacturers may donate to independent patient assistance charities and earmark donations... View Details
Keywords: Cost Sharing; Prescription Drugs; Drug Spending; Medicare; Dual Eligibility; Cost; Health Care and Treatment; Philanthropy and Charitable Giving; Pharmaceutical Industry
Citation
Find at Harvard
Register to Read
Related
Dafny, Leemore, Christopher Ody, and Teresa Rokos. "Giving a Buck or Making a Buck? Donations by Pharmaceutical Manufacturers to Independent Patient Assistance Charities." Health Affairs 41, no. 9 (September 2022).
  • Fast Answer

Student Proposed Fellowship Program - Resources for selecting your organization

The following resources can be used to identify nonprofit organizations: Identifying Organizations  Search Strategies GuideStar Pro - Information about the missions, programs, and finances of more than 1.7 million nonprofit... View Details
  • 01 Dec 2004
  • News

Finding a Balance

political issues for students, so it fits well with the LCA curriculum.” Cipla’s CEO, Dr. Yusef Hamied, figures prominently in the case. A Cambridge University–educated chemist, Hamied is revered by some for his humanitarian projects (including several View Details
Keywords: Julia Hanna; Colleges, Universities, and Professional Schools; Educational Services
  • Article

Biosimilars and Follow-On Products in the United States: Adoption, Prices, and Users

By: Ariel Dora Stern, Jacqueline L. Chen, Melissa Ouellet, Mark R. Trusheim, Zeid El-Kilani, Amber Jessup and Ernst R. Berndt
Biologic drugs account for a disproportionate share of the increase in pharmaceutical spending in the U.S. and worldwide. Against this backdrop, many look to the expanding market for biosimilars—follow-on products to biologic drugs—as a vehicle for controlling... View Details
Keywords: Pharmaceuticals; Drug Spending; Drug Pricing; Health Care and Treatment; Spending; Price; Markets; Cost Management; United States
Citation
Find at Harvard
Read Now
Purchase
Related
Stern, Ariel Dora, Jacqueline L. Chen, Melissa Ouellet, Mark R. Trusheim, Zeid El-Kilani, Amber Jessup, and Ernst R. Berndt. "Biosimilars and Follow-On Products in the United States: Adoption, Prices, and Users." Health Affairs 40, no. 6 (June 2021): 989–999.
  • Web

Student Clubs | MBA

Family Business Club Finance Club FinTech Club First Generation Students Club Food and Agriculture Club Football/Soccer Club Formula One Club French-Speaking Club Future of Mobility Future of Work Club G Gaming and Game Industry Club... View Details
  • August 2024
  • Article

How Do Copayment Coupons Affect Branded Drug Prices and Quantities Purchased?

By: Leemore S. Dafny, Kate Ho and Edward Kong
Drug copayment coupons to reduce patient cost-sharing have become nearly ubiquitous for high-priced brand-name prescription drugs. Medicare bans such coupons on the grounds that they are kickbacks that induce utilization, but they are commonly used by... View Details
Keywords: Prescription Drugs; Coupons; Impact; Health Care and Treatment; Markets; Price; Spending; Pharmaceutical Industry; United States
Citation
Find at Harvard
Register to Read
Related
Dafny, Leemore S., Kate Ho, and Edward Kong. "How Do Copayment Coupons Affect Branded Drug Prices and Quantities Purchased?" American Economic Journal: Economic Policy 16, no. 3 (August 2024): 314–346.
  • Web

Courses by Title - Course Catalog

Management Robert Simons Fall 2025 Q1Q2 3.0 The Coming of Managerial Capitalism Entrepreneurial Management Tom Nicholas Spring 2026 Q3Q4 3.0 Corporate Finance: Corporate Financial Operations (CFO) Finance C. Fritz Foley Fall 2025 Q1Q2 3.0... View Details
  • 08 Mar 2017
  • News

A Steady Voice in Difficult Times

Denise Welsh (MBA 1981) is a pediatric chaplain at Mount Sinai Medical Center, a second career after having spent many years in the finance field. In this video, she talks about her role in the intensive care unit and the impact of... View Details
  • 30 Apr 2001
  • What Do You Think?

Dot.Com Shakeout: Chess or Roulette?

was that of T. N. Rao: "There is an immense business opportunity now for all the investing companies to pick up some very good dot.coms that have very sound business models. It is just that the principles of assessing the health of... View Details
Keywords: by James Heskett
  • 18 Feb 2016
  • Blog Post

Honing an Interest in Healthcare at HBS

internship with a well-known healthcare expert organization to do some consulting work. I also took a class in health policy over at the Kennedy School, and spent quite a bit of time in and out of class with a small core of students from... View Details
  • September–October 2020
  • Article

The Past, Present, and (Near) Future of Gene Therapy and Gene Editing

By: Julia Pian, Amitabh Chandra and Ariel Dora Stern
Emerging gene therapy and gene-editing technologies will have a growing impact on patient lives and health-care delivery. We analyzed a decade of data on clinical trials and venture capital investments to understand the likely trajectory of genetically focused... View Details
Keywords: Gene Therapy; Gene Editing; Impact; Health Care and Treatment; Technological Innovation; Health Testing and Trials; Venture Capital; Change
Citation
Find at Harvard
Read Now
Related
Pian, Julia, Amitabh Chandra, and Ariel Dora Stern. "The Past, Present, and (Near) Future of Gene Therapy and Gene Editing." NEJM Catalyst Innovations in Care Delivery 1, no. 5 (September–October 2020).
  • 01 Dec 2004
  • News

Boom Times Ahead

half of next year.” Dent said that the four sectors that represent the best investments are technology, financial services, health care, and Asia. And don’t delay — according to Dent, the boom will end in 2009. View Details
  • August 2025
  • Article

Revenue Collapses and the Consumption of Small Business Owners in the COVID-19 Pandemic

By: Olivia S. Kim, Jonathan A. Parker and Antoinette Schoar
Using financial account data linking small businesses to their owner households, we examine how business owners’ consumption responded to changes in business revenues during the COVID-19 crisis. In the first two months following the National Emergency, business... View Details
Keywords: Revenue; Small Business; Health Pandemics; Spending; Consumer Behavior
Citation
Read Now
Related
Kim, Olivia S., Jonathan A. Parker, and Antoinette Schoar. "Revenue Collapses and the Consumption of Small Business Owners in the COVID-19 Pandemic." Art. 104079. Journal of Financial Economics 170 (August 2025).
  • 09 Jun 2020
  • Working Paper Summaries

Aggregate and Firm-Level Stock Returns During Pandemics, in Real Time

Keywords: by Laura Alfaro, Anusha Chari, Andrew Greenland, and Peter K. Schott
  • Web

Derek Soled Archives | Social Enterprise

Impact Measurement Inclusive Finance International Development K-12 Education Leadership Fellows Leadership in Challenging Times MBA Programs Microfinance Non Profit Management Nonprofit Supportive Services Public Sector Public-Private... View Details
  • July 2002 (Revised December 2002)
  • Case

Phase Two: The Pharmaceutical Industry Responds to AIDS

By: Debora L. Spar
Describes how major pharmaceutical firms changed their strategy and pricing policies in the years 2000 to 2002 to respond to the growing AIDS epidemic in Africa. View Details
Keywords: International Finance; Health Pandemics; Corporate Social Responsibility and Impact; Pharmaceutical Industry; Africa
Citation
Educators
Purchase
Related
Spar, Debora L., and Nick Bartlett. "Phase Two: The Pharmaceutical Industry Responds to AIDS." Harvard Business School Case 703-005, July 2002. (Revised December 2002.)
  • Profile

Zayed Muhammed Yasin

gives me the ability to mobilize and organize resources to address the big health problems among people who need the most help," he says. "If you understand finances and operations, you can find... View Details
  • 13 Dec 2016
  • First Look

December 13, 2016

fundamental firm value, which is gradually revealed into prices. Publisher's link: https://www.hbs.edu/faculty/Pages/item.aspx?num=51971 December 2016 Harvard Business Review Health Care Needs Real Competition By: Dafny, Leemore S., and... View Details
Keywords: Carmen Nobel
  • ←
  • 39
  • 40
  • …
  • 66
  • 67
  • →
ǁ
Campus Map
Harvard Business School
Soldiers Field
Boston, MA 02163
→Map & Directions
→More Contact Information
  • Make a Gift
  • Site Map
  • Jobs
  • Harvard University
  • Trademarks
  • Policies
  • Accessibility
  • Digital Accessibility
Copyright © President & Fellows of Harvard College.